Publisher: Adis International
ISSN: 1173-5503
Source: PharmacoEconomics and Outcomes News, Vol.1, Iss.260, 2000-01, pp. : 5-5
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Costs associated with triple screening for Down's syndrome
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 350, 2002-01 ,pp. :
Lactulose drives down costs of encephalopathy-related MVAs
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 645, 2012-01 ,pp. :
Costs for branded drugs up, generics down in US
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 625, 2011-01 ,pp. :
Resource use, costs down in first year of DM programme
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 472, 2005-01 ,pp. :
Is Canada's medicines review board really holding down costs?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 394, 2003-01 ,pp. :